Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01829152

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Verizon Wireless (from the registry)
Registry
  • NCT NCT01829152
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01829152. Randomized; no masking; primary purpose screening. Start 2013-12 (registry gives no type); primary completion 2014-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure
Condition
Heart Failure
Intervention (Device)
CHM
Lead sponsor
Verizon Wireless (class: industry)

Record details

Record id
cardio:ct-nct01829152
Content hash
4dfaa7aa14e43ac234f7e033a14bd68344b074106114eca94e47f4651b416bc1